Cite
HARVARD Citation
Willmann, S. et al. (2021). PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients. CPT: pharmacometrics & systems pharmacology. pp. 890-901. [Online].